McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
前日終値
$938.84
+$8.59 · +0.92%
日中の時刻はETです。市場データは遅延する場合があります。
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
日中レンジ
現在 $938.84
52週レンジ
現在 $938.84
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
75
割安
センチメント
63
強気
リスク
22
中程度のリスク
モメンタム
47
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
日中レンジ
現在 $938.84
52週レンジ
現在 $938.84
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 4034.3億 USD | 3590.51億 USD | 3089.51億 USD | 2767.11億 USD | 2639.66億 USD |
| 売上原価 | 3888.8億 USD | 3465.66億 USD | 2967.49億 USD | 2648.42億 USD | 2513.17億 USD |
| 粗利益 | 145.5億 USD | 124.85億 USD | 122.02億 USD | 118.69億 USD | 126.49億 USD |
| 研究開発 | 1.03億 USD | 9100万 USD | 7700万 USD | 8900万 USD | 7000万 USD |
| 販売・一般管理 | −80.96億 USD | 80.22億 USD | 81.98億 USD | 73.27億 USD | 98.56億 USD |
| 営業費用 | 80.96億 USD | 81.13億 USD | 82.75億 USD | 74.16億 USD | 99.26億 USD |
| 受取利息 | 1.79億 USD | 1.73億 USD | 1.18億 USD | 1.07億 USD | 1000万 USD |
| 支払利息 | 2.47億 USD | 2.56億 USD | 2.43億 USD | 2.48億 USD | 1.78億 USD |
| 減価償却費と償却費 | 7.29億 USD | 6.36億 USD | 6.35億 USD | 6.08億 USD | 7.6億 USD |
| 営業利益 | 64.54億 USD | 43.72億 USD | 39.27億 USD | 44.53億 USD | 27.23億 USD |
| 純利益 | 47.62億 USD | 32.95億 USD | 30.02億 USD | 35.6億 USD | 11.14億 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$956.43
上昇余地(1.87%)分割調整後の1株当たりの年間現金分配金。
$3.06
2025年(通年)+71.9% 以来 2021
2026年(一部):$2.58
$1.78
2,021
$2.02
2,022
$2.32
2,023
$2.66
2,024
$3.06
2,025
$2.58
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年9月1日 | $0.94Quarterly | 2026年9月1日 | 2026年10月1日 |
配当 | 2026年6月1日 | $0.82Quarterly | 2026年6月1日 | 2026年7月1日 |
配当 | 2026年3月2日 | $0.82Quarterly | 2026年3月2日 | 2026年4月1日 |
配当 | 2025年12月1日 | $0.82Quarterly | 2025年12月1日 | 2026年1月2日 |
配当 | 2025年9月2日 | $0.82Quarterly | 2025年9月2日 | 2025年10月1日 |
配当 | 2025年6月2日 | $0.71Quarterly | 2025年6月2日 | 2025年7月1日 |
配当落ち 2026年9月1日
$0.94
Quarterly
2026年9月1日基準 · 支払日 2026年10月1日
配当落ち 2026年6月1日
$0.82
Quarterly
2026年6月1日基準 · 支払日 2026年7月1日
配当落ち 2026年3月2日
$0.82
Quarterly
2026年3月2日基準 · 支払日 2026年4月1日
配当落ち 2025年12月1日
$0.82
Quarterly
2025年12月1日基準 · 支払日 2026年1月2日
配当落ち 2025年9月2日
$0.82
Quarterly
2025年9月2日基準 · 支払日 2025年10月1日
配当落ち 2025年6月2日
$0.71
Quarterly
2025年6月2日基準 · 支払日 2025年7月1日
この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T2092.79億0.16%129.34兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI33.81億0.14%2.3兆 USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO28.26億0.16%1.8兆 USD0.03%$715.59+0.61%
iShares Core S&P 500 ETFIVV14.42億0.16%8927.95億 USD0.03%$781.97+0.60%
State Street SPDR S&P 500 ETFSPY13.22億0.16%8172億 USD0.09%$778.57+0.60%
Vanguard Morningstar Value ETFVTV10.17億0.39%2624億 USD0.03%$220.59+0.44%
State Street Health Care Select Sector SPDR ETFXLV7.72億1.77%435.37億 USD0.08%$170.81+1.58%
Vanguard Dividend Appreciation ETFVIG6.02億0.45%1324億 USD0.04%$239.05+0.70%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。